Author

Young Song

National Institutes of HealthPrimary ORCID profile (0000-0003-0580-1600 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Young SongiD1 paper · Pacific Northwest National Laboratory

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aanandi MunshiiD· 1 shared Ara JoiD· 1 shared Archana SinghiD· 1 shared Audrey L. ChambersiD· 1 shared Corinne Mary LinardiciD· 1 shared Daniel LeeiD· 1 shared Darrell GreeniD· 1 shared Elizabeth A. MendesiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aanandi MunshiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma

Elizabeth A. Mendes, Aanandi Munshi, Archana Singh, Maisie D. Evans, Hsien-Chao Chou, Yong Yean Kim, Young Song, Ara Jo, Daniel Lee, Jaida Ciampi, Audrey L. Chambers, Samantha Weitzel, Michael D. Deel, Rex C. Bentley, Javed Khan, , Corinne Mary Linardic

This study identifies RUNX2 as a druggable target in fusion-positive rhabdomyosarcoma, showing its inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and reduces tumor growth.

bioRxiv · Jul 21, 2025 · PreprintCancer Biology